- Home
- SQM vs ASND Comparison
SQM vs ASND Comparison
Compare SQM & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SQM | ASND |
|---|---|---|
| Founded | 1968 | 2006 |
| Country | Chile | Denmark |
| Employees | N/A | N/A |
| Industry | Mining & Quarrying of Nonmetallic Minerals (No Fuels) | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.9B | 17.1B |
| IPO Year | 1997 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SQM | ASND |
|---|---|---|
| Price | $76.43 | $270.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 16 |
| Target Price | $68.80 | ★ $281.50 |
| AVG Volume (30 Days) | ★ 841.4K | 459.1K |
| Earning Date | 05-26-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.74% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $96.35 |
| Revenue Next Year | $7.83 | $44.91 |
| P/E Ratio | $39.64 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $40.58 | $186.05 |
| 52 Week High | $98.00 | $282.15 |
Technical Indicators
Market Signals| Indicator | SQM | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 59.67 | 64.98 |
| Support Level | $76.60 | $213.28 |
| Resistance Level | $85.22 | $282.15 |
| Average True Range (ATR) | 2.51 | 8.13 |
| MACD | 0.25 | 1.94 |
| Stochastic Oscillator | 60.87 | 91.49 |
Price Performance
Historical ComparisonAbout SQM Sociedad Quimica y Minera S.A.
Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM also sells lithium concentrate from a joint venture hard rock lithium project in Australia and expanding its lithium refining assets in China.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.